Consensus DaShenLin Pharmaceutical Group Co., Ltd.

Equities

603233

CNE100002RG2

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
21.78 CNY +0.83% Intraday chart for DaShenLin Pharmaceutical Group Co., Ltd. -1.13% -12.53%

Evolution of the average Target Price on DaShenLin Pharmaceutical Group Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

3971b962f2f.ygK4ONZ0pOP3Cf39LeJdRyY351GquFnh4osCIDVoq1w.vFjJAKUr87SVaJOKbs8Cal5xkRbzyi7Z2tM7UAcS72qzT85KlRzOlL1mzQ~e7f6a9a80a236af90be668f028efa373

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
21.78 CNY
Average target price
32.99 CNY
Spread / Average Target
+51.46%
High Price Target
38 CNY
Spread / Highest target
+74.47%
Low Price Target
28.3 CNY
Spread / Lowest Target
+29.94%

Consensus detail

Consensus revision (last 18 months)

Analysts covering DaShenLin Pharmaceutical Group Co., Ltd.

UBS
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. 603233 Stock
  4. Consensus DaShenLin Pharmaceutical Group Co., Ltd.